Company profile: Captario
1.1 - Company Overview
Company description
- Provider of a cloud-based SaaS platform and services for strategic decision-making in drug development. Captario SUM offers modeling and simulation to create, compare, and optimize project and portfolio pathways by value and risk, with visual project modeling and portfolio functionality. Services include portfolio management, project strategy analysis, managed portfolios, simulation-based portfolio forecasts, and quantitative disease area strategy.
Products and services
- Captario SUM: Cloud-based simulation software that architects visual project models and portfolio scenarios to create, compare, and optimize alternative drug-development pathways for value and risk-based decisions
- Project Strategy Analysis: 30-day analytic service that produces comprehensive analysis of project strategy options covering timelines, risk, value, and cost to guide comparative decision-making
- Portfolio Management: 30-day reporting service that delivers rapid portfolio reports to assist strategic decision-making, providing the first portfolio overview ready within 30 days
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Captario
Stacs DNA
HQ: United States
Website
- Description: Provider of sample tracking software for forensics and healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stacs DNA company profile →
Horizon Lab Systems
HQ: United States
Website
- Description: Provider of configurable, secure LIMS for clinical and medical labs, integrating with Clinisys. Offers HORIZON LIMS (sample management, data collection, reporting; cloud or on‑premise), LabOnline portal, Logbook ELN, Field offline data capture, instrument integration for automation and data import, and analytical, financial, and operational reporting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Horizon Lab Systems company profile →
Octant
HQ: United States
Website
- Description: Provider of a cellular intelligence platform for studying protein misfolding in human cells and enabling high-throughput screening; multiplexed readouts to measure protein folding and trafficking across hundreds of mutations and conditions; and development of novel therapeutics guided by massive datasets in engineered human cells to improve health and treat disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Octant company profile →
RxData
HQ: United States
Website
- Description: Provider of a global market access data platform offering on-demand, automated pharmaceutical pricing and reimbursement insights. Solutions include comprehensive market access intelligence, exportable dashboards, real-time monitoring of 100+ sources, curated HTA/regulatory data, visible net price algorithms, and an internal data repository.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RxData company profile →
Evolved By Nature
HQ: United States
Website
- Description: Provider of Activated Silk biotechnology that creates biobased molecules from natural silk protein to enhance and protect surfaces across therapeutics, textiles and personal care. Offerings include a leather biofinishing system replacing harmful petrochemicals, textile finishing agents for nylon and polyester, skincare ingredients supporting the skin barrier and collagen, and biosurfactants for petrochemical-free soaps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evolved By Nature company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Captario
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Captario
2.2 - Growth funds investing in similar companies to Captario
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Captario
4.2 - Public trading comparable groups for Captario
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →